The upregulation of PD‐L1 expression on lung cancer cells has been shown to occur in response to IFN‐γ released by TAMs, primarily through activation of the JAK/STAT3 and PI3K/AKT pathways, while the MAPK/ERK pathway had no significant effect. Here, AKT1 is linked to lung cancer.